4-Methylphenylboronic Acid

We are 4-Methylphenylboronic Acid CAS:5720-05-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name:  4-Methylphenylboronic Acid
Other Name:
4-Methylphenylboronic Acid
4-Tolylboronic acid
CAS No: 5720-05-8
MF: C7H9BO2
MW: 135.95600
Density: 0.911g/cm3
Boiling point: 178.7ºC at 760 mmHg
Melting point: 256-263 °C(lit.)
Flash point: 61.6ºC
Refractive index: 1.505
UN Number: UN2206
Transport hazard class: 6.1
Packing group: III
 
Specification
Appearance: White powder
Assay: ≥99.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
4-Methylbenzeneboronic Acid is a useful synthetic intermediate. 
It can be used as a catalyst for Suzuki-Miyaura cross-coupling of aryl bromides. 
It can also be used as a reagent for Palladium (Pd)-catalyzed direct arylation.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

4-Methylphenylboronic Acid


Related News: The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.clorhidrato de etil (1S, 3aR, 6aS) -octahidrociclopenta [c] pirrol-1-carboxilato CAS:1147103-42-1 The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.2,6-Dichloropurine CAS:5451-40-1 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.318515-70-7 Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.

Related Products
Product Name
1,1,1-Trifluoroethane Cas:420-46-2 View Details
Veratrole View Details
α,α,α’,α’-Tetramethyl-5-methyl-1,3-benzenediacetonitrile View Details
Dicyclohexylamine manufacturer perfluoro-n-butane sulfonamide Cas:30334-69-1 manufacturer 1-Bromo-4-(trifluoromethoxy)benzene manufacturer benzododecinium chloride Cas:139-07-1 manufacturer pentane-2,3-dione manufacturer